We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.37%
2 Financials 4.87%
3 Healthcare 3.8%
4 Consumer Discretionary 3.79%
5 Industrials 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGRN
9851
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-3,475
Closed -$31K
SYNH
9852
PUT
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-38,900
Closed -$2.01M
INFI
9853
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-10,300
Closed -$19K
RTL
9854
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
-11,231
Closed -$121K
QUOT
9855
DELISTED
Quotient Technology Inc
QUOT
-334,800
Closed -$3.4M
QUOT
9856
PUT
DELISTED
Quotient Technology Inc
QUOT
-18,400
Closed -$182K
NEX
9857
CALL
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-41,300
Closed -$450K
UNVR
9858
DELISTED
Univar Solutions Inc.
UNVR
-319,411
Closed -$6.98M
SPPI
9859
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-27,300
Closed -$292K
NMTR
9860
DELISTED
9 Meters Biopharma
NMTR
-2,752
Closed -$106K
IMBI
9861
CALL
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
-1,250
Closed -$6K
NYMX
9862
DELISTED
Nymox Pharmaceutical Corp
NYMX
-23,544
Closed -$41.2K
USX
9863
CALL
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-11,800
Closed -$78K
QDYN
9864
DELISTED
FlexShares Quality Dividend Dynamic Index Fund
QDYN
-31,712
Closed -$1.38M
BNSO
9865
DELISTED
Bonso Electronic International
BNSO
-12,123
Closed -$36K
RNDM
9866
DELISTED
First Trust Developed International Equity Select ETF
RNDM
-4,167
Closed -$207K
ROCC
9867
PUT
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
-6,500
Closed -$287K
FIHD
9868
DELISTED
UBS AG FI Enhanced Global High Yield ETN
FIHD
-1,889
Closed -$323K
RUTH
9869
PUT
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-34,700
Closed -$888K
KSPN
9870
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
-2,365
Closed -$20K
BAL
9871
DELISTED
iPath Series B Bloomberg Cotton Subindex Total ReturnSM ETN
BAL
-4,397
Closed -$189K
APTO
9872
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
-51
Closed -$46K
APTO
9873
DELISTED
Aptose Biosciences, Inc.
APTO
-73
Closed -$66K
ACOR
9874
CALL
DELISTED
Acorda Therapeutics
ACOR
-186
Closed -$296K
AQUA
9875
CALL
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-16,600
Closed -$209K

Similar funds

Citadel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
  • Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.